Literature DB >> 2462602

Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents.

J L Kadurugamuwa1, B Hengstler, O Zak.   

Abstract

We studied the effects of ampicillin and anti-inflammatory agents on cerebrospinal fluid (CSF) protein patterns in rabbits with meningitis caused by Streptococcus pneumoniae. CSF proteins were analyzed in the acute phase of infection and during convalescence by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by two types of staining or by immunoblotting. During the acute phase a massive influx of serum albumin into the CSF was accompanied by the appearance of other proteins of high and low molecular weight. In untreated animals and animals given ampicillin alone or together with indomethacin, the abnormal pattern persisted for up to 30 d. Combined treatment with ampicillin and dexamethasone or oxindanac, a new nonsteroidal anti-inflammatory drug, partially prevented the alterations in CSF protein patterns. Reversion to normal CSF protein patterns was fastest in these two groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462602     DOI: 10.1093/infdis/159.1.26

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Hearing impairment after bacterial meningitis: a review.

Authors:  H M Fortnum
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

Review 2.  Animal models as predictors of the safety and efficacy of antibiotics.

Authors:  O Zak; T O'Reilly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

3.  Corticosteroids in bacterial meningitis.

Authors:  R G Finch; C Mandragos
Journal:  BMJ       Date:  1991-03-16

4.  Animal models in the evaluation of antimicrobial agents.

Authors:  O Zak; T O'Reilly
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

5.  Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response.

Authors:  Jagath L Kadurugamuwa; Kshitij Modi; Olivier Coquoz; Brad Rice; Steven Smith; Pamela R Contag; Tony Purchio
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 6.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 7.  Inflammatory properties of antibiotic-treated bacteria.

Authors:  Andrea J Wolf; George Y Liu; David M Underhill
Journal:  J Leukoc Biol       Date:  2016-08-30       Impact factor: 4.962

Review 8.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

Review 9.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

Review 10.  Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage.

Authors:  Liise-Anne Pirofski; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.